KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Total Debt (2016 - 2025)

Historic Total Debt for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $202.7 million.

  • West Pharmaceutical Services' Total Debt rose 4.94% to $202.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.7 million, marking a year-over-year increase of 4.94%. This contributed to the annual value of $202.6 million for FY2024, which is 17829.67% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Total Debt of $202.7 million as of Q3 2025, which was up 4.94% from $202.6 million recorded in Q2 2025.
  • Over the past 5 years, West Pharmaceutical Services' Total Debt peaked at $254.6 million during Q1 2021, and registered a low of $72.8 million during Q4 2023.
  • Its 5-year average for Total Debt is $192.3 million, with a median of $206.7 million in 2022.
  • Within the past 5 years, the most significant YoY rise in West Pharmaceutical Services' Total Debt was 17829.67% (2024), while the steepest drop was 6505.04% (2024).
  • Over the past 5 years, West Pharmaceutical Services' Total Debt (Quarter) stood at $253.0 million in 2021, then dropped by 18.3% to $206.7 million in 2022, then crashed by 64.78% to $72.8 million in 2023, then skyrocketed by 178.3% to $202.6 million in 2024, then grew by 0.05% to $202.7 million in 2025.
  • Its Total Debt stands at $202.7 million for Q3 2025, versus $202.6 million for Q2 2025 and $202.6 million for Q1 2025.